Eutilex.Co.Ltd Asset Resilience Ratio

Latest as of September 2025: 0.11%

Eutilex.Co.Ltd asset resilience ratio. Eutilex.Co.Ltd (263050) has an Asset Resilience Ratio of 0.11% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 263050 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩54.65 Million

≈ $37.04K USD Cash + Short-term Investments

Total Assets

₩51.00 Billion

≈ $34.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Eutilex.Co.Ltd (2016–2024)

Asset resilience ratio of Eutilex.Co.Ltd from 2016 to 2024. This chart shows how Eutilex.Co.Ltd's Asset Resilience Ratio has changed over time. Read debt load of Eutilex.Co.Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Eutilex.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 263050 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩54.65 Million	0.11%
Total Liquid Assets	₩54.65 Million	0.11%

Asset Resilience Insights

Limited Liquidity: Eutilex.Co.Ltd maintains only 0.11% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Eutilex.Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Eutilex.Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Eutilex.Co.Ltd Asset Resilience Ratio by Year (2016–2024)

Eutilex.Co.Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Eutilex.Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.55%	₩19.66 Billion ≈ $13.32 Million	₩66.51 Billion ≈ $45.07 Million	-23.04pp
2023-12-31	52.59%	₩38.24 Billion ≈ $25.91 Million	₩72.70 Billion ≈ $49.27 Million	-11.90pp
2022-12-31	64.49%	₩67.37 Billion ≈ $45.66 Million	₩104.46 Billion ≈ $70.79 Million	+0.59pp
2021-12-31	63.91%	₩72.65 Billion ≈ $49.23 Million	₩113.68 Billion ≈ $77.04 Million	-0.27pp
2020-12-31	64.18%	₩67.73 Billion ≈ $45.90 Million	₩105.54 Billion ≈ $71.52 Million	+10.77pp
2019-12-31	53.41%	₩40.59 Billion ≈ $27.51 Million	₩76.01 Billion ≈ $51.51 Million	-20.24pp
2018-12-31	73.65%	₩62.65 Billion ≈ $42.46 Million	₩85.06 Billion ≈ $57.65 Million	+3.80pp
2017-12-31	69.85%	₩40.85 Billion ≈ $27.69 Million	₩58.49 Billion ≈ $39.64 Million	+12.00pp
2016-12-31	57.85%	₩18.25 Billion ≈ $12.37 Million	₩31.55 Billion ≈ $21.38 Million	--

pp = percentage points

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24379 Global

#1737 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩1480.00

All Time High

₩41553.86